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ABSTRACT The current investigation aimed to generate data to inform the de- 
velopment of  risk assessments of  biocide usage. Stabilized domestic drain bio-   
ﬁlm microcosms were exposed daily over 6 months to increasing concentrations 
(0.01% to 1%) of the biocide benzalkonium chloride (BAC) in a simple aqueous 
solution (BAC-s) or in a complex formulation (BAC-f) representative of a domestic 
cleaning agent. Bioﬁlms were analyzed by culture, differentiating by bacterial 
functional group and by BAC or antibiotic susceptibility. Bacterial isolates were 
identiﬁed by 16S rRNA sequencing, and changes in bioﬁlm composition were as- 
sessed by high-throughput sequencing. Exposure to BAC-f resulted  in  signiﬁ-  
cantly larger reductions in levels of viable bacteria than exposure to BAC-s, while 
bacterial diversity greatly decreased during exposure to both BAC-s and BAC-f, as evi- 
denced by sequencing and viable counts. Increases in the abundance of bacteria exhib- 
iting reduced antibiotic or BAC susceptibility following exposure to BAC at 0.1% were 
signiﬁcantly greater for BAC-s than BAC-f. Bacteria with reduced BAC and antibiotic 
susceptibility were generally suppressed by higher BAC concentrations, and for- 
mulation signiﬁcantly enhanced this effect. Signiﬁcant decreases in the antimi- 
crobial susceptibility of bacteria isolated from the systems before and after long- 
term BAC exposure were not detected. In summary, dose-dependent suppression  
of bacterial viability by BAC was enhanced by formulation. Biocide exposure de-  
creased bacterial diversity and transiently  enriched  populations  of  organisms  
with lower antimicrobial susceptibility, and the effects were subsequently sup- 
pressed by exposure to 1% BAC-f, the concentration most closely reﬂecting de- 
ployment in formulated products. 
IMPORTANCE Assessment of the risks of biocide use has been based mainly on the 
exposure of axenic cultures of bacteria to biocides in simple aqueous solutions. The 
current investigation aimed to assess the effects of formulation on the outcome of 
biocide exposure in multispecies bioﬁlms. Formulation of the cationic biocide BAC 
signiﬁcantly increased antimicrobial potency. Bacteria with lower antimicrobial sus- 
ceptibility whose populations were enriched after low-level biocide exposure were 
more effectively suppressed by the biocide at in-use concentrations (1% [wt/vol]) in   
a formulation than in a simple aqueous solution. These observations underline the 
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he potential for the home environment to act as a reservoir for bacterial pathogens 
has long been considered by epidemiologists (1, 2). In particular, the domestic sink 
drain has been identiﬁed as a potential risk due to continual hydration and nutrient 
availability, which promotes microbial growth and the establishment of taxonomically 
diverse bioﬁlms (3, 4). The open nature of the drain allows its continuous inoculation 
with a plethora of microorganisms originating both from food waste (5) and, poten- 
tially, in the case of organisms such as Legionella sp., from the tap water (6). While there 
are only a small number of reports in the literature on the microbial ecology of such 
environments, the persistence and recalcitrance of bacterial bioﬁlms are widely ac- 
knowledged (7, 8) and often result in ineffective disinfection by chemical control agents 
(9). Furthermore, the fact that biocide-containing formulations are diluted from the 
point of application within a drain system to sublethal concentrations increases the risk 
of resistance selection. Bacterial bioﬁlms are also recognized for the spread of antibiotic 
resistance determinants between species within the bioﬁlm via horizontal gene trans- 
fer, further adding to concern over their role in the spread of antimicrobial resistance 
within  the  domestic  environment (10). 
The widespread use of products containing biocides has led to concern over the 
potential selection of bacteria exhibiting reduced susceptibility to the primary antimi- 
crobial compound and potentially to third-party agents such as chemically unrelated 
biocides and antibiotics through the induction of cross-resistance (11–13). Quaternary 
ammonium compounds (QACs) are cationic biocides with  broad-spectrum  antimicro-  
bial activity that are widely used as antiseptics, disinfectants, and preservatives (14). The 
antibacterial efﬁcacy and surfactant-like properties of QACs such as benzalkonium 
chloride (BAC) have led to their use in a variety of domestic cleaning and personal care 
products (14, 15). Increased expression of multidrug efﬂux pumps in certain bacteria     
has been previously associated with reductions in susceptibility both to BAC and 
antibiotics (16–18). 
While the generation of non-biocide-susceptible bacteria has been reported for 
certain combinations of bacterium and biocide (19, 20), such observations have been 
based mainly on data generated through the exposure of bacteria to biocides in simple 
aqueous solutions in the laboratory. In the real world, biocides are formulated into 
products containing various sequestrants and surfactants that may affect antimicrobial 
potency as well as having mitigating effects on the development of bacterial insus- 
ceptibility (11). Furthermore, data used to assess the risks and beneﬁts of biocide use 
have mostly been generated using pure cultures of bacteria, while bacteria in the 
environment usually exist as complex mixed-species bioﬁlm communities that are 
inherently recalcitrant to antimicrobial treatment (7, 21). 
Assessments of the risks of biocide use have been based mainly on the exposure of 
axenic cultures of bacteria to biocides in simple aqueous solutions. The aim of the 
current study was therefore to investigate the effect of BAC delivered in a simple 
aqueous solution (BAC-s) or in a complex formulation (BAC-f), representative of a 
general-purpose cleaning product, on the bacteriological composition and antibiotic 
and BAC susceptibility properties of a multispecies bioﬁlm community. Domestic drain 
bioﬁlms were chosen because they are (i) taxonomically diverse, with high cell density, 
and (ii) commonly exposed to antibacterial compounds and because (iii) methods for 
their stable maintenance have previously been developed and validated (22–24). 
Susceptibilities of bacteria isolated from constant-depth ﬁlm fermenters (CDFFs) 
before and during BAC exposure to BAC and the antibiotics ampicillin (AMP), 
kanamycin (KAN), ciproﬂoxacin (CIP), cephalothin (CEF), and tetracycline (TET) were 
assessed via plating onto agars containing graded concentrations of BAC and set 
antibiotic concentrations. Bacterial composition in modeled drain bioﬁlms was also 
evaluated by 16S rRNA gene sequencing of isolated culturable bacteria and through 
next-generation sequencing (NGS) analysis of communities using the Illumina  
MiSeq platform. 
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RESULTS 
Assessment of compositional changes in BAC-exposed bioﬁlms by differential 
viable counting. Drain microcosm experiments were run for 8 weeks to stabilize 
bacterial populations prior to BAC exposure. Following 8 subsequent weeks of contin- 
uous  exposure  to  BAC-s  or  BAC-f  at  0.01%  (wt/vol),  the  concentration  was then 
increased to 0.1% (wt/vol) for a further 8 weeks and then to 1% (wt/vol) for a further       
7 weeks. 
With respect to statistically signiﬁcant effects of BAC dosing, the major observations 
were as follows. (i) BAC dosing caused a statistically signiﬁcant decrease  in  total  
bacterial counts (P < 0.01), and formulation of BAC increased antibacterial potency, 
resulting in signiﬁcantly greater bacterial inactivation than that seen with BAC  in  a  
simple aqueous solution (P < 0.001). Immediately after exposure to 0.01% (wt/vol) BAC, 
total aerobic counts had reduced by 6.8 Log10 CFU/mm
2 for BAC-f versus 6.7 Log10 
CFU/mm2 for BAC-s. Counts of enteric bacteria decreased by  6.0  Log10  CFU/mm
2  for BAC-
f versus 6.7 Log10 CFU/mm
2 for BAC-s, while counts of Gram-positive bacteria decreased 
by 6.2 Log10 CFU/mm
2 for both BAC-s and BAC-f. Bacterial viability subse- quently 
increased to numbers approaching the preexposure numbers over the follow-   ing 8 
weeks while the systems were under conditions of continuous exposure to 0.01% 
F1 (wt/vol)  BAC  (Fig.  1A,  panel  i).  In  contrast,  total  anaerobe  and pseudomonas counts 
initially increased regardless of formulation and then subsequently declined to the 
preexposure numbers by week 16. A similar pattern was observed when the dosing 
concentration was increased to 0.1% (wt/vol) BAC. At 0.1% (wt/vol) BAC, a decrease in 
viability was observed within all functional groups of bacteria, with the exception of the 
pseudomonads, which showed an elevation in numbers (Fig. 1A, panel ii). At week 26,   
the dosing concentration was increased to 1% (wt/vol) BAC, reﬂecting the BAC con- 
centration commonly used in household products. At this concentration, a more 
substantial decrease in bacterial viability for all selected functional groups  was  ob-  
served  in  both  the  BAC-s-  and  BAC-f-exposed systems. 
At the end of the antimicrobial exposure period, comparing the total effects of BAC-f 
and BAC-s, respectively, total viable counts were as follows: 3.9 and 6.1 Log10 CFU/mm
2 
for total aerobes, 3.7 and 5.7 Log10 CFU/mm
2 for enteric bacteria, 3.9 and 5.5 Log10 
CFU/mm2 for Gram-positive species, 3.7 and 5.1 Log10 CFU/mm
2 for total anaerobes, 
and 3.2 and 4.3 Log10 CFU/mm
2 for pseudomonads. Signiﬁcantly greater reductions in 
total levels of viable bacteria occurred after exposure to BAC-f at the in-use concen- 
tration (1%) than after exposure to BAC-s (P < 0.001). Statistically signiﬁcant changes 
both in the abundance of different functional groups of culturable bacteria and in the 
abundance of bacteria capable of growing on the antibiotic- and BAC-containing agars 
T1 (P < 0.001) occurred during the BAC exposure period (Fig. 1B and Table 1).  While the 
overall number of viable microorganisms detected on BAC-containing agars decreased 
substantially as the BAC exposure concentration increased, the relative proportion of 
organisms exhibiting low susceptibility to BAC within the total viable population 
increased. Comparing the percentages of the culturable bacterial populations capable 
of growing on BAC-containing agars (Table 1 and Fig. 1) before BAC exposure to those 
measured after exposure, there was an increase in the proportion of bacteria capable 
of growing in the presence of BAC (0.1 to 1,000    µg ml-1). 
BAC-s and BAC-f caused similar increases in the relative abundances of bacteria 
selected on 0.1 µg ml-1 and 1 µg ml-1 BAC-containing agar. In contrast, the increase 
in the relative abundance of bacteria capable of growing in the presence of 10 µg ml-1 
and 100 µg ml-1 BAC observed during exposure to BAC-s was signiﬁcantly greater than 
that seen during exposure to BAC-f (P < 0.001). BAC-s and BAC-f caused similar 
increases in the relative abundances of bacteria capable of growing in the presence of 
T2 1,000  µg ml-1  BAC (Tables  1  and 2  and Fig. 1).  The  growth of  these    bacteria was 
suppressed during exposure to BAC at 1% (P < 0.001), and formulation signiﬁcantly 
increased this effect (P < 0.001). 
With respect to the relative abundances of bacteria capable of growing on 
antibiotic-containing  agars,  increases  were  observed  in  both  systems  at  low BAC 
Forbes  et al. Applied and Environmental Microbiology 
April  2017    Volume  83    Issue  7  e03054-16 aem.asm.org    4 
 
 
zam-aem/zam00717/zam7741d17z xppws S=3 1/31/17 8:57 4/Color  Fig: 2,3,4 ArtID: 03054-16 DOI:10.1128/AEM.03054-16 CE: jtc 
 
 
 
 
FIG 1 Differential viable counts of bacteria in microcosms under conditions of long-term exposure to benzalkonium chloride in simple solution (BAC-s) or 
formulation (BAC-f). (A) Bacteria isolated according to growth on media (i) selective for different functional groups of bacteria or (ii) containing various 
concentrations of BAC. (B) Bacteria isolated according to susceptibility to selected antibiotics. The ﬁrst of the lower arrows indicates commencement of exposure 
to 0.01% BAC, the second arrow, commencement of exposure to 0.1% BAC (weeks 17 to 25), and the third arrow, commencement of exposure to 1% BAC. Amp, 
ampicillin; Cep, cephalothin; Cip, ciproﬂoxacin, Kan, kanamycin; Tet, tetracycline. 
 
concentrations. However, at the in-use concentration (1%), the counts decreased for 
the bacteria regardless of the antibiotic. Statistical modeling suggests that effects on 
bacteria capable of growing on antibiotic selection plates could be grouped as follows: 
the bacteria growing on the CIP and KAN selection plates showed similar population 
decreases; those growing on AMP and CEP plates showed similar, larger decreases; and 
those growing on TET plates underwent the largest  decrease. 
The species of bacteria isolated on agars containing BAC or antibiotics before and 
after exposure to 1% (wt/vol) BAC-s and BAC-f were determined through sequencing of 
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TABLE 1 Changes in the relative proportions of bacteria isolated on BAC- and antibiotic- 
containing  agars  before  and  after  exposure  to  1%  (wt/vol)  BAC  in  simple  aqueous 
solution  or  in  complex  formulation  with  sequestrants  and surfactants 
   
 
BAC (0.1) 31.2 31.1 
BAC (1) 30.5 30.7 
BAC (10) 89.9 21.3 
BAC (100) 75.7 27.8 
BAC (1,000) 7.0 9.0 
Ampicillin 32.6 37.3 
Cephalothin 36.9 42.7 
Ciproﬂoxacin 18.7 42.5 
Kanamycin 60.8 -7.4 
Tetracycline 12.6 -3.7 
aData represent average percent changes in levels of bacteria isolated on agars containing BAC or antibiotics 
before (0% [wt/vol] BAC, weeks 6 to 8) and after (1% [wt/vol] BAC, weeks 30 to 32) exposure to formulated 
BAC (BAC-f) or unformulated BAC (BAC-s). Relative proportions of bacteria on selective agars were  
calculated as the percentages of total aerobic microorganisms present each week. Change data represent 
increases unless otherwise indicated. 
 
 
 
 
 
T3 
T4/AQ:C 
the 16S rRNA gene (Table 2). Isolates varied in their abundance throughout the BAC 
exposure period, with insusceptible organisms that grew from potentially undetectable 
levels prior to BAC treatment becoming more prevalent. The biocide (Table 3) and 
antibiotic (Table 4) susceptibilities of numerically dominant culturable bacteria that 
could be isolated from the microcosms both before and during or after BAC exposure 
were determined. Data indicate that the increased abundance of bacteria selected on 
BAC- or antibiotic-containing agars was not reﬂected in reductions in susceptibility in 
these isolated bacteria (Tables 3 and 4). Determination of MIC and minimum bacteri- 
cidal concentrations (MBC) for BAC in bacteria isolated before and after BAC-s or BAC-f 
exposure showed a <2-fold change in susceptibility for certain combinations of 
bacterium and exposure conditions. Minor increases and decreases in antibiotic sus- 
ceptibility were observed in isolates after BAC-s or BAC-f exposure, although no 
bacterial isolate became resistant according to British Society for Antimicrobial Che- 
motherapy (BSAC) criteria (23). 
 
 
TABLE 2 Bacteria isolated from the drain microcosms before and after exposure to BAC-s or BAC-f, corresponding to data presented in 
Fig. 1a 
 
Wk 
Bacterial species isolated before or after exposure to BAC ([µg ml-1]): 
BAC-s BAC-f 
4  (before BAC exposure) Bacillus cereus (BAC 0.1, CEF, KAN), Aeromonas    hydrophilia 
(BAC 0.1, AMP), Elizabethkingia meningoseptica (AMP, 
CEF, CIP, KAN), Achromobacter spanius (BAC 0.1), 
Sphingobacterium spiritovorum (CEF), Chryseobacterium 
pallidium (TET) 
Bacillus cereus (BAC 0.1, CEF, KAN), Aeromonas hydrophilia 
(BAC 0.1, AMP), Elizabethkingia meningoseptica (AMP, 
CEF, CIP, KAN), Delftia lacustris (KAN), Aeromonas DH6 
(KAN), Chryseobacterium pallidium  (TET) 
 
24 (during exposure to 
0.1%  [wt/vol] BAC) 
 
Bacillus cereus (BAC 0.1; CEF, KAN), Elizabethkingia 
meningoseptica (AMP, CEF, CIP, KAN), Aeromonas 
hydrophilia (BAC 0.1, AMP), Stenotrophas maltophilia 
(BAC 0.1), Pseudomonas geniculata (BAC 0.1, AMP), 
Enterobacter cloacae (BAC  0.1) 
 
Bacillus cereus (BAC 0.1, CEF, KAN), Elizabethkingia 
meningoseptica (AMP, CEF, CIP, KAN), Aeromonas 
hydrophilia (BAC 0.1, AMP), Stenotrophomonas pavanii 
(BAC 0.1), Pseudomonas geniculata (BAC 0.1, AMP), 
Pseudomonas putida (BAC 0.1,  AMP) 
 
32 (during exposure to 
1% [wt/vol] BAC) 
 
Bacillus cereus (BAC 0.1, BAC 1.0, CEF, TET), Alcaligenes sp. 
(BAC 0.1, CIP, KAN), Pseudomonas sp. (BAC 0.1,    CEF), 
Pseudomonas aeruginosa (BAC 0.1, AMP), Pseudomonas 
nitroreducens (AMP) 
 
Bacillus cereus (BAC 0.1, BAC 1.0, CEF), Alcaligenes sp. 
(BAC 0.1) 
 
aOrganisms represent numerically dominant culturable bacteria that were isolated on media containing BAC or antibiotics before (week 4) and after (weeks 24   and 
32) microcosm exposure to formulated BAC (BAC-f) or unformulated BAC (BAC-s) (week 24, 0.1% [wt/vol] BAC; week 32, 1% [wt/vol] BAC). Isolates were identiﬁed by 16S 
rRNA gene sequencing. Acronyms refer to agar containing BAC or antibiotics as follows: BAC 0.1, BAC at 0.1 µg ml-1; BAC 1.0, BAC at 1 µg ml-1; AMP,        ampicillin; 
CEF, cephalothin; CIP, ciproﬂoxacin; KAN, kanamycin; TET, tetracycline. 
Isolated on agar containing 
(µg ml-1): 
% change after exposure  toa: 
BAC-s BAC-f 
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TABLE 3 Susceptibility to benzalkonium chloride of bacteria isolated before, during, and 
after exposure of microcosms to BAC-s or BAC-fa 
            
          
          
          
Aeromonas hydrophilab 31.3 31.3  31.3 62.5  31.3 31.3  31.3 31.3 
Bacillus cereusc 7.8 7.8  7.8 7.8  7.8 7.8  7.8 7.8 
Elizabethkingia meningosepticab 7.8 15.6  15.6 15.6  7.8 15.6  15.6 15.6 
aMICs and minimum bactericidal concentrations of bacteria isolated from systems treated with BAC in simple 
solution (BAC-s) or in complex formulation with sequestrants and surfactants (BAC-f) before and after 
exposure to BAC. The indicated isolates were the only organisms isolated before and after the BAC    
exposure regimen. 
b0.1%  (wt/vol) BAC. 
c1.0%  (wt/vol) BAC. 
 
 
AQ: D 
 
Prior to exposure to BAC-s, Bacillus cereus, Aeromonas hydrophila, and Achromobac- 
ter spanius were detected on BAC-containing agars, while Alcaligenes sp., Pseudomonas 
spp., and B. cereus were detected after exposure to 1% (wt/vol) BAC (Table 2). In 
comparison, in the BAC-f-treated system, B. cereus and A. hydrophila were selected on 
BAC-containing agars prior to exposure whereas B. cereus and an Alcaligenes sp. were 
isolated after exposure. On agars containing the indicated antibiotics (Table 2), Eliza- 
bethkingia meningoseptica (AMP, CEF, CIP, and KAN), B. cereus (CEF and KAN), A. 
hydrophila (AMP), Sphingobacterium spiritivorum (CEF), and Chryseobacterium pallidum 
(TET) were isolated from the BAC-s system before exposure whereas B. cereus (CEF and 
TET), Alcaligenes sp. (CIP and KAN), and multiple Pseudomonas spp. (CEF and AMP) were 
isolated after exposure. In contrast, in the BAC-f-treated system, Elizabethkingia menin- 
 
 
TABLE 4 Antibiotic susceptibility in bacteria isolated before, during, and after exposure of 
microcosms to BAC-s or BAC-fa 
       
     
     
Aeromonas hydrophilab AMP 
CEF 
CIP 
KAN 
TET 
ns 
ns 
18 
ns 
8.3 (0.6) 
ns 
ns 
17.7 (1.1) 
ns 
8.0 
 ns 
ns 
17.3 (0.6) 
ns 
9.0 
ns 
ns 
17.0 
ns 
9.3 (0.6) 
B. cereusc AMP 
CEF 
ns 
21.0 (1.0) 
ns 
22.0 (2.0) 
 ns 
23.0 (1.0) 
ns 
25.3 (0.6) 
 CIP 18.6 (0.6) 22.3 (1.5)  18.3 (0.6) 19.0 
 KAN 10.7 (0.6) 8.3 (0.6)  11.0 10.3 (0.6) 
 TET 10.7 (0.6) 20.3 (0.6)  10.3 (1.5) 20.3 (1.5) 
E. meningosepticac AMP 
CEF 
CIP 
KAN 
TET 
6.0 
ns 
18.0 
ns 
8.3 (0.6) 
6.0 (1.0) 
ns 
17.7 (1.1) 
ns 
8.0 
 6.0 (1.0) 
ns 
17.3 (0.6) 
ns 
9.0 
5.7 (0.6) 
ns 
17.0 
ns 
9.3 (0.6) 
aAntibiotic susceptibility of bacteria isolated from systems treated with BAC in simple solution (BAC-s) or in 
complex formulation with sequestrants and surfactants (BAC-f) before and after exposure to BAC. Units are 
in mm (n = 3). Values in parentheses represent ●●●. ns, nonsusceptible (i.e., no inhibition observed). See 
footnotes to Tables 1 and 3. 
b0.1%  (wt/vol) BAC. 
c1.0%  (wt/vol) BAC. 
 
 
 
 
 
 
 
Bacterium 
MIC or MBC (mg ml-1) under indicated conditions of 
exposure to BAC in microcosms (n = 6) as: 
BAC-f 
Before After 
exposure exposure 
MIC MBC MIC MBC 
BAC-f 
Before 
exposure 
MIC MBC 
After 
exposure 
MIC MBC 
 
 
 
 
 
 
Bacterium Antibiotic 
Susceptibility (mm) under indicated conditions of 
exposure to BAC in microcosms,  as: 
BAC-s 
Before After 
exposure exposure 
BAC-f 
Before After 
exposure exposure 
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FIG 2 Relative abundances of bacterial genera detected at >1% relative abundance in drain microcosms 
before (weeks 1 to 8) and after exposure to 0.01% BAC (weeks 9 to 16), 0.1% BAC (weeks 17 to 25), and 
1% BAC (weeks 26 to 32). (A) BAC-s. (B) BAC-f. See legend to Fig.   1. 
 
 
goseptica (CIP, AMP, CEF, and KAN), Delftia lacustris (KAN), Aeromonas sp. strain DH6 
(KAN), A. hydrophila (AMP), and B. cereus (CEF and KAN) were isolated prior to BAC 
exposure whereas only B. cereus (CEF) was isolated after exposure. 
High-throughput sequence analysis of bacterial diversity. NGS analysis identi-  
ﬁed ca. 416 observable species from drain microcosms prior to biocide exposure. 
Elizabethkingia predominated, representing 20% and 35.6% of the bacterial    relative 
F2 abundance during exposure to BAC-f and BAC-s, respectively (Fig. 2).   This bacterium 
increased in abundance following exposure to 0.01% (relative abundance, 41.03% ± 
1.49%) and 0.1% (relative abundance, 47.35% ± 0.08%) BAC-s before decreasing in 
abundance to levels below the baseline following exposure to 1.0% BAC-s (relative 
abundance, 13.0% ± 12.48%). Reductions in the relative abundances of sequences 
associated with Elizabethkingia were marked, with concomitant increases in Clos- 
tridium sp., Aeromonas sp., and Achromobacter during exposure to 1.0% (wt/vol) 
BAC-f (Fig. 2, top panel). For exposure to BAC-f, despite ﬂuctuations in the relative 
abundance of Elizabethkingia spp. following dosing with 0.01% BAC (40.69% ± 
40.97%), this genus remained at levels comparable to baseline during microcosm 
exposure to 0.1% (37.8% ± 7.11%) and 1.0% (25.4% ± 6.52%) BAC-s (Fig. 2, bottom 
panel). 
The results of ordination of unweighted UniFrac distances suggest that baseline 
microcosm samples exhibited a degree of homology in terms of the presence/absence 
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FIG 3 Changes in drain microcosm population dynamics in response to exposure to concentrations of benzalkonium chloride in aqueous solution (BAC-s) or  
in complex formulation (BAC-f). Ordinations were generated following principal-coordinate analyses of unweighted UniFrac distances. Numbers denote 
sampling time points (weeks). See legend to Fig.  1. 
 
 
F3 of identiﬁed taxa between independent model runs (Fig. 3). During week 32 (1.0% 
BAC-f and BAC-s), samples from CDFFs exposed to BAC-s and BAC-f clustered together, 
independently from other samples. The most signiﬁcant changes in relative abundance 
of detected genera occurred at a 1% exposure concentration for both BAC-f and BAC-s 
F4 (Fig.  4).  NGS  analysis  revealed  signiﬁcant  decreases  and  increases  in        the  relative 
abundances of detectable genera after exposure to 1% (wt/vol) BAC-s  or  BAC-f,  
reﬂecting the in-use concentration. Data indicate larger numbers of signiﬁcant changes 
(both increases and decreases) in detectable genera after treatment with BAC-f than  
after treatment with BAC-s. There were signiﬁcant decreases in the relative abundances 
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FIG 4 Signiﬁcant (P < 0.01) changes in relative abundances in individual OTUs between microcosms left unexposed or exposed to 1% BAC. (Top panel) BAC-s. 
(Bottom panel) BAC-f. See legend to Fig.  1. 
 
 
of operational taxonomic units (OTUs) assigned to Chryseobacterium, Stenotrophomo- 
nas, Comamonas, Klebsiella, Achromobacter, Erwinia, Pseudomonas, and Bradyrhizobium 
for 1% (wt/vol) BAC-s and BAC-f exposure (Fig. 4). BAC-s was also  associated  with  
relative decreases in OTUs assigned to Delftia and Luteolibacter and Aeromonas. In- 
creases in the relative abundances in detectable genera showed greater diversity  
between the systems, with the only consistent relative increases occurring for OTUs 
assigned to Sphingobacterium, Sediminibacterium, Niabella, Pedobacter, Anaerovorax, 
Coprococcus, Dokdonella, Leucobacter, Delftia, Gemmata, Methyloversatilis, Comamonas, 
Flavobacterium, and Stenotrophomonas during exposure to both BAC-s and BAC-f. 
 
DISCUSSION 
Investigations into potential risks of the development of biocide resistance have 
focused largely on the exposure of pure cultures of bacteria to active antimicrobials, 
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such as quaternary ammonium compounds, in simple aqueous solutions (25, 26). In the 
environment, however, bacteria form complex, multispecies bioﬁlm communities, and 
biocides are deployed in formulation with various sequestrants and surfactants. 
In the current investigation, the effects of the formulation of the quaternary am- 
monium compound benzalkonium chloride (BAC) on biocide and antibiotic suscepti- 
bility in bacteria maintained within a domestic drain bioﬁlm microcosm were investi- 
gated. The approach to establishing domestic bioﬁlm ecosystems has been previously 
validated for the maintenance of compositionally stable microcosms established using 
excised domestic drain bioﬁlms. By utilizing this approach, the effects of long-term 
biocide exposure on a microbial community representative of a common biocide- 
exposed domestic environment can be determined (22). 
While exposure to BAC both in a simple aqueous solution and in formulation caused 
substantial decreases in bacterial diversity, exposure to the biocide in a complex 
formulation resulted in greater overall reductions in total levels of viable bacteria (Fig. 
1). Relative abundances of bacteria capable of growing on BAC- and antibiotic- 
containing agars increased transiently in both systems during exposure to lower 
concentrations of BAC, probably associated with the clonal expansion of B. cereus, 
Alcaligenes sp., and Pseudomonas spp. The relatively low intrinsic susceptibility of these 
bacteria to biocides and antibiotics has been widely documented in previous reports 
(17, 27–29). Increases in the abundance of such organisms may accompany reductions 
in the levels of the more BAC-susceptible bacteria. This may be due to the decreased 
competition for nutrients which has been previously reported in similar microcosm 
systems, and it further supports the reduction in overall bacterial viability observed in 
both of our systems after BAC treatment (22, 23). Bacteria isolated from the microcosms 
exhibited minor (<2-fold) reductions in BAC susceptibility after BAC exposure in testing 
in planktonic culture (MIC and minimum bactericidal concentration [MBC]). BAC con- 
centrations that inhibited the growth of these bacteria were, however, considerably 
lower than the concentrations of selective agar on which the bacteria were initially 
isolated from the microcosms and ca. 100-fold lower than the BAC concentrations to 
which the microcosms were exposed. The former may have been due to differences in 
the methodologies, and the latter may be indicative of the well-documented recalci- 
trance associated with growth in the bioﬁlm phenotype. 
Low susceptibility to BAC in pseudomonads has been previously attributed to  
increases in the expression or activity of multidrug tolerance efﬂux pumps that can 
actively remove QACs, such as BAC, from the cytoplasmic membrane core, thereby 
reducing their antibacterial efﬁcacy (20, 21).  Since  multidrug  efﬂux  pump  expression 
has also been associated with changes in bacterial susceptibility  to  chemically  unre- 
lated third-party agents (22), it has been suggested that efﬂux-mediated decreases in  
QAC susceptibility can be accompanied by changes in the effectiveness of clinically 
important antibiotics against certain bacteria (30). B. cereus spores are insusceptible to 
BAC and therefore may germinate on agar plates, likely explaining the apparent 
prevalence of this bacterium after biocide exposure (31). While no documentation of 
comparatively low susceptibility to BAC in aeromonads has been previously reported, 
insusceptibility to ampicillin in this genus is common (32). Ampicillin insusceptibility in 
pseudomonads has been widely reported, and tetracycline resistance has also been 
documented for various chryseobacteria (33). Multidrug resistance has been reported in 
numerous clinical isolates of E. meningoseptica, an environmental bacterium (34, 35). 
While induced changes in bacterial susceptibility in various pure cultures of bacteria in 
response to BAC exposure have been reported (30, 36), data generated in the current 
investigation suggest that the compositional changes associated with altered antimi- 
crobial susceptibility proﬁles within the bioﬁlm were most likely attributable to  the  
clonal expansion of bacterial species, such as B. cereus and pseudomonas, that are 
reportedly innately insusceptible to these antimicrobial agents. This suggestion was 
supported by further susceptibility testing of key isolates, where substantial decreased 
susceptibility  was  not observed. 
A previous investigation into the effects of the formulation of biocides in  reducing 
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the development of insusceptibility in monospecies cultures of bacteria suggested that 
formulated biocides exhibited greater antibacterial potency than unformulated actives 
and that susceptibility decreases after repeated exposure were lower in frequency and 
extent (11, 37). This association among formulation, increased antibacterial potency, 
and the partial mitigation of antimicrobial insusceptibility therefore also appeared to 
hold true in mixed-species bioﬁlms, as outlined in the current  investigation. 
Formulated biocides are likely to interact with bacteria in a manner that is distinct 
from that seen in simple aqueous solutions, since the excipients that are present, 
particularly surfactants, may associate with additional cellular targets, enhance bacterial 
permeability, or solubilize the active compound. This is likely to be partly responsible 
for increased overall antimicrobial potency of the formulation. For example, nonionic 
surfactants, such as alcohol ethoxylates, found in the formulation used in the current 
investigation, have previously shown bacteriostatic effects due to their destabilizing 
impact on the bacterial cell membrane, leading to an increase in membrane permea- 
bility and potentially facilitating the entry of other agents such as BAC into the bacterial 
cell (38). Additionally, the formulation included chelating agents such as sodium 
tripolyphosphate, which may, as is the case with many chelators, have antimicrobial 
activity due to its ability to disrupt the bacterial cell envelope (39). This may occur 
through the sequestering of stabilizing divalent cations, causing the release of lipo- 
polysaccharides from the cell envelope and consequently impairing barrier function 
(40, 41). This provides a plausible explanation for the heightened antimicrobial activity 
observed with the BAC formulation compared to the simple aqueous BAC  solution. 
As expected, NGS detected considerably higher microbial diversity within the 
microcosms than could be detected by culture, highlighting the limitation of the use of 
culture-based analysis alone when investigating such complex bacterial communities. 
A proportion of the bacteria within the system was therefore not isolated, or, alterna- 
tively, extracellular bacterial DNA may have remained within the bioﬁlm sampled after 
bacterial cell lysis from BAC treatment. However, this is unlikely due to the use of 
propidium monoazide (PMA). Interesting, while B. cereus was among the predominant 
organisms isolated through culture, Bacillus was not among the dominant genera 
detected by NGS. This may have been due to the presence of a high abundance of 
Bacillus spores within the bioﬁlm that were not susceptible to DNA extraction tech- 
niques. 
Conclusion. The formulation of BAC increased antimicrobial potency, which was 
reﬂected in signiﬁcantly greater viability decreases in complex domestic drain bioﬁlm 
microcosms. During exposure to BAC, clonal expansion of innately insusceptible bac- 
teria occurred, mainly in B. cereus and Pseudomonas spp. This increase in the abundance 
of the less antimicrobial-susceptible bacteria was more pronounced after exposure to 
BAC-s than after exposure to BAC-f. The BAC formulation suppressed bacteria with 
reduced levels of BAC and antibiotic susceptibility signiﬁcantly more effectively than 
BAC in a simple aqueous solution. Formulation of BAC therefore mitigated the devel- 
opment of BAC and antibiotic insusceptibility within the mixed-species bioﬁlm micro- 
cosms. Signiﬁcant decreases in antibiotic and biocide susceptibility were not detected 
in monospecies cultures of bacteria isolated from the microcosms before and after 
biocide exposure. 
 
MATERIALS AND METHODS 
Chemicals and growth media. Bacteriological growth media were obtained from Oxoid (Basing- 
stoke, UK). All other chemical reagents were obtained from Sigma-Aldrich (Dorset, UK). Growth media 
were sterilized at 121°C and 15 lb/in2  for 15 min prior to  use. 
Antimicrobials. Benzalkonium chloride (BAC) was obtained from Sigma-Aldrich (Dorset, UK). CIP  (1 
µg), CEF (20 µg), AMP (10 µg), KAN (5 µg), and TET (10 µg) antibiotic discs were obtained from Oxoid 
(Basingstoke, UK). BAC was tested both in a simple aqueous solution and in a formulation representative 
of a general-purpose cleaner at 1% (wt/vol), reﬂective of its normal use in consumer products, and 
containing sodium tripolyphosphate (a chelator) and alcohol ethoxylates (nonionic surfactants) as 
previously described (11). 
Domestic drain bioﬁlm microcosms. Bioﬁlm samples (1 g) were removed using a sterile scraper and 
a collection tube from the horizontal pipe section of a polyvinyl chloride (PVC) kitchen drain outlet in a 
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household that did not use biocidal products apart from bleach. The samples were transported to the 
laboratory for processing within 2 h. The drain bioﬁlm was macerated by vortex mixing using glass beads 
in 20 ml of phosphate-buffered saline (PBS) (0.01 M, pH 7.4) for 5 min to produce a slurry which was 
subsequently used to inoculate paired sterile constant-depth ﬁlm fermenter (CDFF) systems. After initial 
CDFF inoculation, the drain medium was run continuously through the system and consisted of the 
following (values represent milligrams per milliliter in tap water): starch, 1.0; peptone, 0.5; tryptone, 0.5; 
yeast extract, 0.5; NaCl, 1.0; margarine (Flora; Unilever, London, UK), 0.05; domestic detergent (Fairy 
Original; Procter and Gamble, Newcastle Upon Tyne, United Kingdom), 0.05; hemin, 0.001; and tomato 
ketchup (Heinz, Uxbridge, United Kingdom). For the initial 8 weeks, the CDFF systems remained 
antimicrobial free. Subsequently, one system was dosed with BAC incorporated into a formulation 
representative of a domestic general-purpose cleaning agent containing 3% nonionic surfactant and 
0.5% sequestrant (BAC-f) and a second system was exposed to BAC in a simple aqueous solution (BAC-s). 
Both systems were exposed to solutions containing increasing concentrations (0.01% to 1%) of BAC for 
the remaining 28 weeks. 
Differential counting of viable bacteria. To evaluate the microbial composition of the CDFF 
systems, bioﬁlm samples were removed for culture-based analysis and were resuspended in 1 ml of 
sterile PBS. Aliquots (0.1 ml) of appropriate dilutions of bioﬁlm slurry were plated in triplicate onto the 
following selective agars: tryptone soya agar (TSA) (for total counts), Wilkins-Chalgren agar (WC) (for total 
strict and facultative anaerobes), MacConkey agar (MK) (for enteric bacteria), Pseudomonas selective agar 
(C-F-C) (for pseudomonads), and Columbia colisitin naladixic acid agar (CCNA) (for Gram-positive 
species). For bioﬁlm community antimicrobial susceptibility proﬁling, bacteria were plated onto TSA 
containing 0.1, 1, 10, 100, or 1,000 µg ml-1 BAC or KAN (10 µg ml-1), CIP (1 µg ml-1), CEF (25 µg ml-1), 
TET (10 µg ml-1), or AMP (25 µg ml-1) antibiotic at concentrations previously used in an investigation 
into the effects of biocide use on antibiotic susceptibility in bacteria within the domestic environment 
(42). The plates were incubated for up to 5 days either aerobically or in an anaerobic chamber (Don 
Whitley Scientiﬁc, Shipley, United Kingdom) (atmosphere, H2 [10%], CO2 [10%], and N2 [80%]) prior to 
enumeration of bacteria. 
16S rRNA gene sequencing of bacterial isolates. Single bacterial colonies were aseptically trans- 
ferred to a microcentrifuge tube containing 100 µl of NANOpure water, subjected to vortex mixing for 
30 s, and boiled at 100°C for 15 min to lyse cells. Microcentrifuge tubes were centrifuged at 16,000 X g 
using a bench-top centrifuge for 10 min to remove cellular debris. The supernatant was retained as the 
DNA template for the PCR. PCR was performed using primers 8FLP (5=-GAG TTT GAT CCT GGS TCA G-3=) 
and 806R (5=-GGA CTA CCA GGG TAT CTA AT-3=) at 5 µM per reaction. PCR was conducted using a 
TGradient PCR machine (Biometra Göttingen, Germany) and run for 35 thermal cycles consisting of 94°C 
(1 min), 53°C (1 min), and 72°C (1 min). A 15-min elongation step was included in the ﬁnal cycle. PCR 
products were puriﬁed using a QIAquick PCR puriﬁcation kit (Qiagen, West Sussex, UK) per the 
manufacturer’s instructions, and the resulting DNA yield was quantiﬁed using a NanoDrop 2000c UV-vis 
spectrophotometer (Thermo Scientiﬁc, Wilmington, DE, USA). A reaction mixture containing 4 pM 
forward or reverse primer and 40 to 50 ng of DNA in a 10-µl total volume was used for DNA sequencing. 
DNA sequencing was performed using the Applied Biosystems 3730 DNA analysis system at the DNA 
Sequencing Facility within The University of Manchester. 
Determination of biocide and antibiotic susceptibility in  microcosm  isolates.  For  BAC  suscep-  
tibility, MICs were determined using the microdilution method as described previously (25). Brieﬂy, 
overnight bacterial cultures were adjusted to an optical density at 600 nm (OD600) of 0.8 and further    
diluted 1:100 in tryptone soya broth in a 96-well microtiter plate containing doubling dilutions of BAC. 
Plates were incubated at 37°C (24 h) with agitation (100 rpm). The MIC was deﬁned as the lowest 
concentration at which bacterial growth did not occur. Growth was viewed as turbidity (600 nm) in 
comparison to an uninoculated well (negative control) and was detected using a microtiter plate reader 
(PowerWave XS; BioTek, Bedfordshire, United Kingdom). Minimum bactericidal  concentrations  (MBC)  
were determined as stated previously (23, 25, 43). Brieﬂy, aliquots (10 µl) from wells exhibiting  no  
turbidity were spot plated onto TSA prior to 4 days of incubation at 37°C (42). The MBC was deﬁned as     
the lowest concentration of biocide at which no growth occurred after 4 days of incubation. Antibiotic 
susceptibilities were determined for CIP (1 µg), CEF (20 µg), AMP (10 µg), KAN (5 µg), and TET (10 µg).   
Disc diffusion assays were performed according to the British Society for Antimicrobial Chemotherapy 
(BSAC)  disc  diffusion  method  for  antimicrobial  susceptibility  testing (44). 
DNA extraction from bioﬁlms. Bioﬁlm samples were washed three times in 5 ml of PBS (0.01 M, pH   
7.4) before being resuspended in 500 µl PBS containing 50 µM propidium monoazide (PMA), to remove 
extracellular DNA. Samples were incubated in PMA solution for 5 min at room temperature prior to 
inactivation via exposure to a halogen light source for 5 min on ice. Bacterial cells were pelleted by 
centrifugation at 5,000 X g for 10 min, and DNA was extracted using a Qiagen DNeasy blood and tissue 
extraction kit (Qiagen Ltd., West Sussex, UK) per the manufacturer’s instructions. 
High-throughput sequencing of 16S rRNA  gene  amplicons.  Ampliﬁcation  of  the  16S  rRNA  gene  
was performed using primer pair BAKT_341_F/BAKT_805_R (45) with additional Illumina adaptor over-  
hang nucleotide sequences. PCRs were performed using MyTaq red mix (Bioline, UK) and comprised 35 
cycles of 94°C (1 min), 52.6°C (1 min), and 72°C (1 min). Amplicon puriﬁcation was achieved using a     
Qiagen PCR puriﬁcation kit (Qiagen, UK) per the manufacturer’s protocol. Next-generation sequencing     
(2X 300 bp) was performed using the Ilumina MiSeq platform at the Genomic Technologies Core Facility, 
The  University  of Manchester. 
Data processing was performed using QIIME 1.8.0 (46). Mating of paired-end sequences and removal 
of reads containing ambiguous bases were performed using PandaSeq (47). OTU picking was performed 
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using a closed reference strategy at a sequence similarity level of 97% against release 13_8 of the 
Greengenes database (48, 49). Singleton OTUs were discarded from the ﬁnal BIOM table. Experimental 
data (sample data, phylogenetic tree, taxonomy table, OTU table) generated in QIIME were subsequently 
imported into R 3.2.2 and analyzed using Phyloseq (50) following rarefaction to equal sample depths (E 
value, 250,000). Ordinations were performed on unweighted UniFrac distances using Phyloseq 1.13.2. 
Final OTU and taxonomy tables were exported as comma-delimited data tables, and values were 
graphically rendered using Prism version 6.05 (GraphPad Software Inc., La Jolla, CA, USA). Statistically 
signiﬁcant variations in OTUs were determined following log2 transformation of abundance data in 
DESeq2 (51). Dispersions were estimated using a parametric ﬁt type, and the Wald signiﬁcance test was 
used as the test argument. Corrections for multiple testing were performed using the Benjamini- 
Hochberg procedure, with signiﬁcance denoted as an adjusted P value of   <0.01. 
Statistical modeling. The series of nested questions of interest in this study were as follows. (i) (a) 
Does the total bacterial count decline from the pre-1% BAC treatment time point to the post-1% BAC 
treatment time point? (b) If so, do the amounts of count reduction differ under formulated versus 
unformulated conditions? (ii) (a) Do pseudomonad counts decline during BAC treatment? (ii) (b) Does 
BAC formulation inﬂuence the antipseudomonad effect? (iii) (a) Does the count of BAC-insusceptible 
bacteria decline from the pre-BAC treatment time point to the post-BAC treatment time point? (b) If so, 
do the amounts of this decline differ under formulated versus unformulated conditions? (iv) Does the 
BAC concentration in plate count agars (10 versus 1,000 mg/liter) affect how much of a decline is 
observed? (v) (a) Does the count of bacteria capable of growing on media containing antibiotics decline 
from the pre-1% BAC exposure time point to the post-1% BAC exposure time point under different? (b) 
If so, do the amounts of decline differ under formulated versus unformulated conditions? (vi) Does the 
type of antibiotic affect how much of a decline is  observed? 
The nested nature of the questions stated above supports the use of the stepwise modeling 
approach (data not shown), where, at each step, starting with the outer question in the series and 
working inward, the sum of squared residuals (SSR [lower values indicate better ﬁt]) was recorded. An 
F-test was applied to assess the signiﬁcance of the reduction in SSR after each step, with the corre- 
sponding P value reported. A constant model was used to analyze the data for simplicity. In doing so, 
we were assessing how the average bacterial count over time is affected in the groups created by the 
questions above. Below, we provide details of how the constant model was used within the stepwise 
modeling approach. 
In the ﬁrst step, we ﬁtted a constant model to the data of interest. In the second step, we allowed 
the constant value to differ before and after 1% BAC treatment. In the third step (the ﬁnal step for 
question series i and ii), we allowed  the  constant  values  corresponding  to  the  post-1%  BAC 
treatment time point to  differ between the  formulated and  unformulated conditions. For  series iii,       
a fourth (ﬁnal) step was conducted in which we allowed the constant values post-1% BAC treatment 
determined under the formulated and unformulated  conditions  to  differ  with  respect  to  the 
amounts of BAC agar (10 versus 1,000 mg/liter). For series iv, the ﬁnal question involved 5 different 
antibiotic treatments, and so we ﬁrst assumed that all antibiotics  had  different  effects  after 
accounting for  pre- versus post-1% BAC  treatment and  formulated versus unformulated conditions.  
We then analyzed the model parameters and assessed whether the 95% conﬁdence  intervals 
overlapped for certain antibiotics. If they did, we grouped those bacteria together in the next model 
iteration and  assessed via  the  F-test whether this grouping made a  difference to  overall model ﬁt.    
All  statistical  modeling  was  conducted  in  Rv3.1.1. 
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